ST Pharm Co. Ltd. | |
Stock Exchange | Korea Exchange |
EPS |
KRW1145 |
Market Cap |
KRW623.11 B |
Shares Outstanding |
18.66 M |
Public Float |
6.86 M |
Address |
#802, Siheunggongdan 1-Na Siheung-si GY 15086 Korea, Republic Of |
Employees | - |
Website | http://www.stpharm.co.kr |
Updated | 09/14/2018 |
ST Pharm Co., Ltd. develops and manufactures pharmaceutical products. It operates throught the following business divisions: New Drug Contract Manufacturing Organization (CMO), Generic Active Pharmaceutical Ingredients (APIs), Fine Chemical, and Bio. The New Drug CMO business offers services such as process optimization, documentation support, and validation. |